While investor interest in emerging markets picked up in the first quarter of 2019, many seemed to overlook small-cap stocks.
12 May 2019
While investor interest in emerging markets picked up in the first quarter of 2019, many seemed to overlook small-cap stocks in the space. Here, Chetan Sehgal, manager, the Templeton Emerging Markets Smaller Companies Fund, suggests some reasons why investors might want to consider select EM small-cap stocks.
Almost all major asset classes experienced declines in 2018—it was clearly a challenging year. EM small-cap stocks (as defined by the MSCI EM Small Cap Index) were not immune, suffering double-digit declines. However, the asset class saw a rebound in the first quarter of this year, as the index delivered a gain of 7.8%.1
Yet, in a continuation from last year, EM small caps didn’t keep pace with their EM large-cap counterparts in the first quarter.2 In our view, part of this underperformance can be attributed to some investor misconceptions about EM small caps. As we mentioned in this article, these misconceptions, such as a view that EM small caps are more volatile than larger-cap EM stocks, conceal key strengths that an active manager could potentially benefit from.
The EM small-cap space remains attractive to us, partly because many of the headwinds in 2018 have already been priced into valuations or are likely to abate this year. The US Federal Reserve (Fed) has taken a more dovish tone this year. At its March 2019 meeting, the Fed confirmed the patient tone on interest rates it already adopted in January.
Also, in terms of US-China trade relations, signs are pointed more optimistically that there will be a near-term agreement, although the possibility that a trade agreement is not reached is a major tail risk.
In addition, the market’s general expectation is that oil prices will remain relatively range-bound, given continued growth in supply and weakened demand with a global economic slowdown. In our view, stable oil prices should support consumption and ease inflation for certain Asian economies, such as India, that are net importers of oil.
We think for many investors the current market environment provides a particularly attractive entry point. In particular, we like select companies in the health care sector, as well as companies that stand to benefit from long-term secular trends relating to consumption and innovation.
Demographic shifts and aging populations in many emerging-market countries are intensifying pressures on health care systems. In our view, these factors will continue to be a boon for hospitals, dietary supplements, medical devices and pharmaceuticals.
The health care landscape is also changing, with growing consumer awareness fuelling medical and wellness needs. We are seeing more consumers embrace preventive health care out of a desire to look and feel better.
For example, we like the long-term prospects for a South Korean company that produces products using botulinum toxin type A for both therapeutic purposes and aesthetic purposes. This company has entered the global botulinum toxin market and we think it is well-positioned to benefit from the growing global demand for anti-aging products, particularly in fast-growing economies such as China where this segment is forecast to grow fast in the decades ahead.
Rising domestic consumption remains a long-term secular driver for emerging markets. We believe the demand for goods and services in emerging markets is set to accelerate on the back of a burgeoning young and working population, coupled with rising household incomes.
In our view, this growing demand will create opportunities for businesses that tap into the growing consumer market. In particular, we like select companies that stand to benefit from the rising trend of premiumisation of consumer goods and services. We also see rising incomes driving demand for more sophisticated financial products and services such as wealth management and asset management.
Emerging-market companies have not only embraced the use of technology but have become global market innovators in many areas. As we mentioned in this article, emerging markets are now at the forefront of the latest technological developments, from mobile banking and shopping to robotics, autonomous vehicles, health care and more.
We expect technology to continue to reshape emerging markets, as technology disruptors become the norm by transforming industry landscapes, and companies continue to embrace technology and innovation.
Technology is changing the automobile industry, introducing new trends such as electric vehicles and automated driving systems. In addition, e-commerce is still very much a penetration story, resonating in several markets as consumers increasingly use multiple devices for online transactions.
Perhaps what is most important to recognise is that there are numerous EM small-cap companies that will likely remain small, whether due to corporate governance issues, poor quality of management, lack of market growth or other factors. The role of an active manager is to seek out companies which will succeed over the long term, while striving to reduce downside risk and thus enhance risk-adjusted returns.
At Franklin Templeton Emerging Markets Equity, we believe active managers who can focus on risk management and long-term growth drivers for the asset class are best equipped to uncover opportunities in this space. Our EM small-cap research is driven by an extensive on-the-ground team of over 80 portfolio managers and analysts in 16 countries, which allows us to have regular face-to-face meetings.
Overall, with our bottom-up, high-conviction, long-term investment approach we look to invest in companies with good management teams, where we have conviction that they can make the right strategic choices.
Important Information
For Professional Client Use Only. Not for Distribution to Retail Clients.
© Copyright 2019. Franklin Templeton Investments. All rights reserved. This document is intended to be of general interest only and does not constitute legal or tax advice nor is it an offer for shares or an invitation to apply for shares of any of Franklin Templeton Investments’ fund ranges. Nothing in this document should be construed as investment advice. Franklin Templeton Investments has exercised professional care and diligence in the collection of information in this document. However, data from third party sources may have been used in its preparation and Franklin Templeton Investments has not independently verified, validated or audited such data. Opinions expressed are the author’s at the publication date and they are subject to change without prior notice. Given the rapidly changing market environment, Franklin Templeton Investments disclaim responsibility for updating this material. Investments entail risks. The value of investments and any income received from them can go down as well as up, and investors may not get back the full amount invested. Past performance is not an indicator, nor a guarantee of future performance. Currency fluctuations may affect the value of overseas investments. When investing in a fund denominated in a foreign currency, performance may also be affected by currency fluctuations. In emerging markets, the risks can be greater than in developed markets. Any research and analysis contained in this document has been procured by Franklin Templeton Investments for its own purposes and is provided to you only incidentally. Franklin Templeton Investments shall not be liable to any user of this document or to any other person or entity for the inaccuracy of information or any errors or omissions in its contents, regardless of the cause of such inaccuracy, error or omission. For more information about any Franklin Templeton Investments’ fund, UK investors should contact: Franklin Templeton Investments, Telephone: 0800 313 4049, Email: ftisalessupport@franklintempleton.co.uk or write to us at the address below. Alternatively, the information can be downloaded from our website www.franklintempleton.co.uk. Issued by Franklin Templeton Investment Management Limited (FTIML) Registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL. FTIML is authorised and regulated by the Financial Conduct Authority.
Source: MSCI, as of March 29, 2019. The MSCI EM Small Cap Index is a free float-adjusted, market capitalisation-weighted index designed to measure performance of small cap equities in emerging markets. Indexes are unmanaged and one cannot directly invest in them. They do not include fees, expenses or sales charges. Past performance is not an indicator or guarantee of future results.
Ibid. The MSCI Emerging Markets Index captures large- and mid-cap representation across 24 emerging-market countries. Indexes are unmanaged and one cannot directly invest in them. They do not include fees, expenses or sales charges. Past performance is not an indicator or guarantee of future results.